SecBot SecBot
SECBOTREPLAY Home › Report › TEVA

TEVA · Director Form 3 filed

TEVA PHARMACEUTICAL INDUSTRIES LTD · 3 filed Nov 12, 2026 at 16:03 ET

At the news

NEUTRALIMPACT 2/10

3 filed Nov 12, 2026 at 16:03 ET

David J. Brailer filed a Form 3 initial statement of beneficial ownership upon becoming a non-executive director of Teva Pharmaceutical Industries. The filing includes a power of attorney authorizing officers to handle Section 16 reporting. No securities ownership amounts are disclosed in the filing.

  • David J. Brailer appointed as non-executive director of Teva Pharmaceutical Industries Ltd.
  • Form 3 filed on 2026-11-12 for period beginning 2026-11-03.
  • Power of attorney executed on 2026-10-26 authorizing Dov Bergwerk, Shira Aran-Porat, and Matan Kimchi to handle Section 16 filings.
  • No beneficial ownership amounts reported in the filing documents.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access